Show Notes
Episode 11: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the September issue of the Journal of Thoracic Oncology. Shun Lu, MD, PhD, Associate editor for the Journal of Thoracic Oncology; Director of Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine discusses their article SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China; and Hidetoshi Hayashi, MD, PhD, Department of Medical Oncology, Kindai University Faculty of Medicine discusses their article Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report.
Recommended Reading: -SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China G22 https://www.jto.org/article/S1556-0864(26)00166-8/fulltext -Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report https://www.jto.org/article/S1556-0864(26)00347-3/fulltext -JTO Volume 21, Issue 9 - September 2026 https://www.jto.org/issue/S1556-0864(26)X2009-3
Podcast Hosts: -Alex A. Adjei, MD, PhD, FACP, Editor-in-Chief, Journal of Thoracic Oncology; Chief, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA -Thomas John, MBBS, PhD, Associate Editor, Journal of Thoracic Oncology, Deputy Director, Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Podcast Guests: -Shun Lu, MD, PhD; Associate editor for the Journal of Thoracic Oncology; Director of Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China -Hidetoshi Hayashi, MD, PhD, Department of Medical Oncology, Kindai University Faculty of Medicine, Sakai, Osaka, Japan
More from JTO Insights
Episode 13: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the October issue of the Journal of Thoracic Oncology. Sai Yendamuri, MD, MBA, FACS, Director of the Thoracic Surgery Research Laboratory at Roswell Park Comprehensive Cancer Center in Buffalo, New York discusses their article Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction; and Mitsuhiro Isaka, MD, PhD, Deputy Chair of the Division of Thoracic Surgery at the Shizuoka Cancer Center in Shizuoka, Japan discusses their article Segmentectomy Versus Lobectomy in NSCLC With Pathologically Invasive Features: A Post Hoc Supplementary Analysis of Multicenter, Phase 3 Trial JCOG0802/WJOG4607L.
In this episode of JTO Insights, recorded at the 2026 World Conference on Lung Cancer, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Karen Reckamp, Professor of Medicine, Division of Medical Oncology at Cedars Sinai Medical Center, joins us to discuss their article, "The Evolution of Immunotherapy Revolution in Lung Cancer: a 20 Year Perspective."
Episode Summary Episode 10: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Jean-Louis Pujol, Professor at Montpellier School of Medicine of Montpellier University in France, joins us to discuss their article, "Lung cancer patient advocacy progress and new challenges since 2006".
Episode 9: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John speak with authors of two articles published in the August issue of the Journal of Thoracic Oncology. Michael J. Grant, MD, Assistant Professor of Medicine in the Section of Medical Oncology at Yale School of Medicine in New Haven, Connecticut, discusses “ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer.” Christian Rolfo, MD, PhD, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at The James Comprehensive Cancer Center, The Ohio State University, discusses “Molecular Profiling Across 80,000 Patients With Lung Cancer.”
Episode Summary Episode 8: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John highlight two articles published in the JTO 20th Anniversary Series. Dr. David Ryan of Royal Brompton & Harefield Hospitals, London, joins us to discuss their article, "Interventional Radiology and Thoracic Oncology: 20 Years of Innovation". Also featured in this episode is the article “Advances in Radiological Imaging for Thoracic Oncology: A 20-Year Perspective" by Drs. Jeremy Erasmus and Ioannis Vlahos.